Multi-center, Observational, Drug-utilization Study in Belgium to Evaluate the Use of VIMPAT in Clinical Practice as Adjunctive Treatment of Partial Onset Epilepsy in Subjects Aged 16 and Older.

Trial Profile

Multi-center, Observational, Drug-utilization Study in Belgium to Evaluate the Use of VIMPAT in Clinical Practice as Adjunctive Treatment of Partial Onset Epilepsy in Subjects Aged 16 and Older.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 02 May 2012 Actual patient number changed from 109 to 192 as reported by ClinicalTrials.gov.
    • 23 Apr 2012 Actual patient number added 190 according to ClinicalTrials.gov.
    • 23 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top